Posts

Track 20: Ovarian Cancer – Advancing Innovation in Gynecologic Oncology at the 13th International Cancer and Medical Oncology Conference and Exhibition

Image
Ovarian cancer remains one of the most challenging gynecologic malignancies worldwide due to its often late diagnosis, complex biology, and evolving therapeutic landscape. Track 20: Ovarian Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition, scheduled for February 1–2, 2027, at Novotel Al Barsha, Dubai, UAE , provides a dedicated scientific platform for oncologists, gynecologic oncologists, researchers, pathologists, molecular biologists, clinicians, and healthcare professionals to discuss the latest advancements in ovarian cancer prevention, diagnosis, treatment, survivorship, and translational research. About Track 20: Ovarian Cancer Track 20 focuses on comprehensive scientific and clinical discussions surrounding ovarian cancer, one of the leading causes of cancer-related mortality among women globally. The track aims to address key issues in ovarian cancer biology, screening challenges, biomarkers, molecular pathways, genetic predisposition, pre...

Track 19: Brain Tumor at the 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  February 1–2, 2027 | Novotel Al Barsha Dubai Advancing Brain Tumor Research and Neuro-Oncology at a Global Platform Brain tumors remain among the most complex and challenging conditions in oncology, affecting both the central nervous system and overall patient quality of life. Their diagnosis, treatment, and long-term management require a multidisciplinary approach involving neuro-oncologists, neurosurgeons, radiation oncologists, medical oncologists, pathologists, radiologists, and rehabilitation specialists. Track 19: Brain Tumor at the 13th International Cancer and Medical Oncology Conference and Exhibition , scheduled for February 1–2, 2027 in Dubai, UAE , will provide an international scientific platform to discuss the latest advancements in brain tumor diagnosis, treatment innovations, molecular research, neuroimaging, precision medicine, immunotherapy, and patient-centered care. This CME/CPD-accredited conference aims to unite experts, researchers, clinicians, academician...

Track 18: Blood Cancer – Advancing Research, Diagnosis, and Treatment at the 13th International Cancer and Medical Oncology Conference and Exhibition

Image
  Blood cancer remains one of the most complex and impactful areas of oncology, affecting the production and function of blood cells and posing significant challenges in diagnosis, treatment, and long-term patient care. Track 18: Blood Cancer at the 13th International Cancer and Medical Oncology Conference and Exhibition , taking place on February 1–2, 2027 at Novotel Al Barsha, Dubai, UAE , is designed to bring together hematologists, oncologists, researchers, clinicians, academicians, and healthcare innovators to discuss the latest breakthroughs in hematologic malignancies and precision oncology. The conference offers participants a global platform for scientific exchange, networking, and professional development, along with eligibility for 30 CME/CPD Credits for qualified attendees. About Track 18: Blood Cancer Track 18 focuses on cancers that affect the blood, bone marrow, and lymphatic system, including: Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelopro...